About the P. vivax information hub
Video on life-changing treatment to cure relapsing P. vivax malaria.
Join GSK at ASTMH session on Malaria Pre-Clinical Drug Development!
Join MMV and PTH at the upcoming ASTM symposium on Wed, 18 Nov.
Interview with Elisa Vidal on supporting countries to eliminate relapsing malaria
This film shows how MMV is working in partnership with other organizations to develop new tools to combat malaria in Brazil.
The main reason conventional primaquine regimens last 14 days is because this was the time taken to repatriate US military personnel by ship following active service in the Korean War.1 We therefore congratulate Walter Taylor and colleagues2 for finally upending an absurdly impractical 60-year-old legacy and setting a new standard of care. However, convincing policy makers and practitioners to implement this new standard of care presents challenges relating to how risk is perceived and managed.